[1]
2024. EVALUATION OF CYTOTOXIC ACTIVITY OF CANAGLIFLOZIN IN HEPG2 CELL LINES. Journal of Population Therapeutics and Clinical Pharmacology. 31, 9 (Sep. 2024), 1723–1727. DOI:https://doi.org/10.53555/461ss311.